Loading…
Based on limited metadata, Butterfly Expressions LLC received an FDA Warning Letter on July 6, 2020, regarding drug products. Without access to the full letter text or subject line, the specific nature of the violations cannot be determined from the available information. The warning falls under FDA's drug product regulatory authority, though the specific issuing office is not identified in this metadata summary. To understand the particular compliance issues cited, the complete Warning Letter would need to be reviewed.